Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12053023rdf:typepubmed:Citationlld:pubmed
pubmed-article:12053023lifeskim:mentionsumls-concept:C0376358lld:lifeskim
pubmed-article:12053023lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:12053023lifeskim:mentionsumls-concept:C0005558lld:lifeskim
pubmed-article:12053023lifeskim:mentionsumls-concept:C0443619lld:lifeskim
pubmed-article:12053023lifeskim:mentionsumls-concept:C0439855lld:lifeskim
pubmed-article:12053023lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:12053023lifeskim:mentionsumls-concept:C0220922lld:lifeskim
pubmed-article:12053023lifeskim:mentionsumls-concept:C0439792lld:lifeskim
pubmed-article:12053023pubmed:issue4lld:pubmed
pubmed-article:12053023pubmed:dateCreated2002-6-7lld:pubmed
pubmed-article:12053023pubmed:abstractTextThe objective of the present study was to evaluate the usefulness of the combined systematic biopsy with serum prostate-specific antigen-alpha(1)-antichymotrypsin complex (PSA-ACT) level to predict the extent of prostate cancer.lld:pubmed
pubmed-article:12053023pubmed:languageenglld:pubmed
pubmed-article:12053023pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12053023pubmed:citationSubsetIMlld:pubmed
pubmed-article:12053023pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12053023pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12053023pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12053023pubmed:statusMEDLINElld:pubmed
pubmed-article:12053023pubmed:issn0042-1138lld:pubmed
pubmed-article:12053023pubmed:authorpubmed-author:KamidonoSadao...lld:pubmed
pubmed-article:12053023pubmed:authorpubmed-author:MiyakeHideaki...lld:pubmed
pubmed-article:12053023pubmed:authorpubmed-author:HaraShojiSlld:pubmed
pubmed-article:12053023pubmed:authorpubmed-author:ArakawaSoichi...lld:pubmed
pubmed-article:12053023pubmed:authorpubmed-author:HaraIsaoIlld:pubmed
pubmed-article:12053023pubmed:authorpubmed-author:EtoHiroshiHlld:pubmed
pubmed-article:12053023pubmed:authorpubmed-author:YamadaYujiYlld:pubmed
pubmed-article:12053023pubmed:authorpubmed-author:YamanakaNozom...lld:pubmed
pubmed-article:12053023pubmed:authorpubmed-author:OnoYoshiharuYlld:pubmed
pubmed-article:12053023pubmed:authorpubmed-author:TakechiYoshiz...lld:pubmed
pubmed-article:12053023pubmed:copyrightInfoCopyright 2002 S. Karger AG, Basellld:pubmed
pubmed-article:12053023pubmed:issnTypePrintlld:pubmed
pubmed-article:12053023pubmed:volume68lld:pubmed
pubmed-article:12053023pubmed:ownerNLMlld:pubmed
pubmed-article:12053023pubmed:authorsCompleteYlld:pubmed
pubmed-article:12053023pubmed:pagination232-6lld:pubmed
pubmed-article:12053023pubmed:dateRevised2006-10-30lld:pubmed
pubmed-article:12053023pubmed:meshHeadingpubmed-meshheading:12053023...lld:pubmed
pubmed-article:12053023pubmed:meshHeadingpubmed-meshheading:12053023...lld:pubmed
pubmed-article:12053023pubmed:meshHeadingpubmed-meshheading:12053023...lld:pubmed
pubmed-article:12053023pubmed:meshHeadingpubmed-meshheading:12053023...lld:pubmed
pubmed-article:12053023pubmed:meshHeadingpubmed-meshheading:12053023...lld:pubmed
pubmed-article:12053023pubmed:meshHeadingpubmed-meshheading:12053023...lld:pubmed
pubmed-article:12053023pubmed:meshHeadingpubmed-meshheading:12053023...lld:pubmed
pubmed-article:12053023pubmed:meshHeadingpubmed-meshheading:12053023...lld:pubmed
pubmed-article:12053023pubmed:meshHeadingpubmed-meshheading:12053023...lld:pubmed
pubmed-article:12053023pubmed:meshHeadingpubmed-meshheading:12053023...lld:pubmed
pubmed-article:12053023pubmed:year2002lld:pubmed
pubmed-article:12053023pubmed:articleTitlePredicting the extent of prostate cancer using a combination of serum prostate-specific antigen-alpha(1)-antichymotrypsin complex and systematic biopsy.lld:pubmed
pubmed-article:12053023pubmed:affiliationDepartment of Urology, Kobe University School of Medicine, Kobe, Japan.lld:pubmed
pubmed-article:12053023pubmed:publicationTypeJournal Articlelld:pubmed